These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 37880118

  • 1. [Two cases of anti-nuclear matrix protein 2 antibody-positive dermatomyositis sine dermatitis with severe diffuse subcutaneous edema and dysphagia].
    Takahashi Y, Takamiya M, Ichimura Y, Okiyama N, Nishino I, Morimoto N.
    Rinsho Shinkeigaku; 2023 Nov 23; 63(11):737-742. PubMed ID: 37880118
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients.
    Albayda J, Pinal-Fernandez I, Huang W, Parks C, Paik J, Casciola-Rosen L, Danoff SK, Johnson C, Christopher-Stine L, Mammen AL.
    Arthritis Care Res (Hoboken); 2017 Nov 23; 69(11):1771-1776. PubMed ID: 28085235
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Perimysial microarteriopathy in dermatomyositis with anti-nuclear matrix protein-2 antibodies.
    Liu Y, Zheng Y, Gang Q, Xie Z, Jin Y, Zhang X, Deng X, Hao H, Gao F, Zhang Z, Xiong H, Zhang W, Wang Z, Yuan Y.
    Eur J Neurol; 2020 Mar 23; 27(3):514-521. PubMed ID: 31571350
    [Abstract] [Full Text] [Related]

  • 6. Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population.
    Manwatkar A, Padiyar S, Nair A, Jha A, Kumar S, Yadav B, Prakash JAJ, Das JK, Mathew J.
    Clin Rheumatol; 2023 Dec 23; 42(12):3289-3297. PubMed ID: 37801141
    [Abstract] [Full Text] [Related]

  • 7. A Case Report on Rare Presentation of Sporadic Disease: Dermatomyositis Sine Dermatitis-Diagnosis and Management.
    Vahora I, Lingireddy A, Nadella S, Trivedi B, Dihowm F.
    J Investig Med High Impact Case Rep; 2022 Dec 23; 10():23247096221121403. PubMed ID: 36050930
    [Abstract] [Full Text] [Related]

  • 8. [Juvenile-onset anti-nuclear matrix protein 2 (NXP-2) antibody-positive dermatomyositis with joint contractures before manifestation of myositis: a case report].
    Miura E, Taneda T, Umeda Y, Umeda M, Oyake M, Matsushita T, Nishino I, Fujita N.
    Rinsho Shinkeigaku; 2024 Jun 27; 64(6):417-421. PubMed ID: 38797685
    [Abstract] [Full Text] [Related]

  • 9. [A case of dermatomyositis positive for anti-nuclear matrix protein 2 antibody without dermatologic symptoms].
    Takeuchi E, Hirozawa D, Okiyama N, Inoue M, Nishino I, Sugai F.
    Rinsho Shinkeigaku; 2021 Apr 21; 61(4):258-261. PubMed ID: 33762494
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cutaneous and Systemic Findings Associated With Nuclear Matrix Protein 2 Antibodies in Adult Dermatomyositis Patients.
    Rogers A, Chung L, Li S, Casciola-Rosen L, Fiorentino DF.
    Arthritis Care Res (Hoboken); 2017 Dec 21; 69(12):1909-1914. PubMed ID: 28129490
    [Abstract] [Full Text] [Related]

  • 12. A Case of Vesiculobullous Dermatomyositis with Anti-NXP-2 Antibody without Malignancy.
    Naito R, Hiwa R, Inaba R, Murakami K, Kitoh A, Kaku Y, Murata T, Ichimura Y, Okiyama N, Nishino I, Shirakashi M, Onizawa H, Tsuji H, Kitagori K, Akizuki S, Nakashima R, Onishi A, Tanaka M, Yoshifuji H, Morinobu A.
    Mod Rheumatol Case Rep; 2024 Aug 01. PubMed ID: 39087257
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cricopharyngeal bar and dermatomyositis: A cause of rapidly progressive dysphagia.
    Adams CL, Lohan S, Bruce A, Kamalaraj N, Gunaratne S, White R.
    Int J Rheum Dis; 2021 Jan 01; 24(1):125-131. PubMed ID: 33135370
    [Abstract] [Full Text] [Related]

  • 15. Dermatomyositis Presenting with Generalized Subcutaneous Edema.
    Nishioka H, Shindo T, Shimizu H.
    Intern Med; 2023 Jan 01; 62(15):2273-2277. PubMed ID: 37532515
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dermatomyositis associated with generalized subcutaneous edema and Evans syndrome.
    Jung KD, Kim PS, Park HY, Kim CR, Byun JY, Lee DY, Lee JH, Yang JM, Lee ES.
    J Am Acad Dermatol; 2012 Jan 01; 66(1):144-7. PubMed ID: 22030016
    [Abstract] [Full Text] [Related]

  • 18. Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.
    Pozharashka J, Dourmishev L, Rusinova D, Balabanova M, Miteva L.
    Acta Dermatovenerol Croat; 2020 Aug 01; 28(2):120-122. PubMed ID: 32876041
    [Abstract] [Full Text] [Related]

  • 19. Dermatomyositis: Muscle Pathology According to Antibody Subtypes.
    Tanboon J, Inoue M, Saito Y, Tachimori H, Hayashi S, Noguchi S, Okiyama N, Fujimoto M, Nishino I.
    Neurology; 2022 Feb 15; 98(7):e739-e749. PubMed ID: 34873015
    [Abstract] [Full Text] [Related]

  • 20. Clinical characteristics of anti-SAE antibodies in Chinese patients with dermatomyositis in comparison with different patient cohorts.
    Ge Y, Lu X, Shu X, Peng Q, Wang G.
    Sci Rep; 2017 Mar 15; 7(1):188. PubMed ID: 28298642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.